You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Opioid discontinuation

Showing 1 - 25 of 5,457
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid-use Disorder Trial in New York (Vivitrol, Buprenorphine)

Completed
Has Results
  • Opioid-use Disorder
  • New York, New York
    New York State Psychiatric Institute
May 25, 2022

Substance Use Disorders Trial in Boston (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD), BZD discontinuation

Completed
Has Results
  • Substance Use Disorders
  • Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
  • BZD discontinuation protocol
  • Boston, Massachusetts
    Boston Medical Center
Jan 20, 2022

Substance Use Disorders Trial in Pittsburgh, Wilkinsburg (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD),

Recruiting
  • Substance Use Disorders
  • Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
  • Relaxation Therapy
  • Pittsburgh, Pennsylvania
  • +2 more
Aug 2, 2022

Opioid Use Disorder (OUD) Trial in United States (SL-BUP, XR-BUP, XR-NTX)

Recruiting
  • Opioid Use Disorder (OUD)
  • Little Rock, Arkansas
  • +18 more
Jun 8, 2022

Chronic Pain, Opioid Pain Medication Trial in Charleston (Buprenorphine Initiation - Phase I, Gabapentin + Buprenorphine - Phase

Completed
Has Results
  • Chronic Pain
  • Opioid Pain Medication
  • Buprenorphine Initiation - Phase I
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Mar 18, 2021

Opiate Use Disorder, Opiate Withdrawal Syndrome Trial in Providence (App Development and Open Pilot)

Completed
  • Opiate Use Disorder
  • Opiate Withdrawal Syndrome
  • App Development and Open Pilot
  • Providence, Rhode Island
    Butler Hospital
Aug 12, 2020

Chronic Pain, Back Pain, Neck Pain Trial (Tizanidine, MI-Opioid Taper, Placebo)

Not yet recruiting
  • Chronic Pain
  • +3 more
  • (no location specified)
Sep 7, 2023

Primary Care Opioid Taper Plans on Sustained Opioid Taper

Completed
  • Opiate Replacement Therapy
  • Taper Plan
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute
Aug 19, 2019

Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)

Not yet recruiting
  • Opioid Use Disorder
  • Opioid Withdrawal
  • BXCL501 (180 micrograms)
  • +3 more
  • (no location specified)
Jan 24, 2023

Opioid Withdrawal (Disorder) Trial in United States (Lofexidine, Placebo)

Suspended
  • Opioid Withdrawal (Disorder)
  • Placentia, California
  • +11 more
Mar 11, 2022

Opioid Prescribing and Use for Acute Pain in Diverse Populations

Recruiting
  • Opioid Use
  • Opioid Prescribing
  • Short-acting opioid prescription for acute pain
  • Birmingham, Alabama
  • +4 more
Feb 3, 2022

Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)

Not yet recruiting
  • Opioid Withdrawal (Disorder)
  • Standard of Care with Lofexidine
  • Standard of Care without Lofexidine
  • (no location specified)
Sep 14, 2023

Opioid-use Disorder, Opioid Use, Opioid Abuse Trial in Minneapolis (Choice Architecture Nudge, PMP Integration & Nudge)

Recruiting
  • Opioid-use Disorder
  • +2 more
  • Choice Architecture Nudge
  • PMP Integration & Nudge
  • Minneapolis, Minnesota
    University of Minnesota
Aug 3, 2022

Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse Trial in United States (Structured discontinuation of opioid therapy

Terminated
Has Results
  • Opioid-Related Disorders
  • +3 more
  • Structured discontinuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER)
  • Continuation of opioid therapy (morphine sulfate ER, oxycodone ER, oxymorphone ER)
  • Foley, Alabama
  • +60 more
Oct 18, 2019

SUBLOCADE Long-term Outcomes

Not yet recruiting
  • Opioid Use Disorder
    • (no location specified)
    May 5, 2023

    Opioid Induced Respiratory Depression, Chronic Opioid Use Trial in Leiden (Narcan 40 MG/ML Nasal Spray, Naloxone Hydrochloride)

    Recruiting
    • Opioid Induced Respiratory Depression
    • Chronic Opioid Use
    • Narcan 40 MG/ML Nasal Spray
    • Naloxone Hydrochloride
    • Leiden, ZH, Netherlands
      Leiden University Medical Center
    Jan 12, 2023

    Opioid Use Disorder, Chronic Pain, Anxiety Trial in Costa Mesa (Virtual Tai Chi Easy)

    Not yet recruiting
    • Opioid Use Disorder
    • +2 more
    • Virtual Tai Chi Easy
    • Costa Mesa, California
      Asana Recovery
    May 3, 2023

    Opioid Use Disorder, Moderate, Opioid Use, Opioid Dependence Trial (unilateral transcranial photobiomodulation)

    Not yet recruiting
    • Opioid Use Disorder, Moderate
    • +5 more
    • unilateral transcranial photobiomodulation
    • (no location specified)
    Aug 15, 2023

    Opiate Withdrawal Syndrome Trial in Manchester, London (DMX-1002, Placebo)

    Recruiting
    • Opiate Withdrawal Syndrome
    • Manchester, Greater Mancherster, United Kingdom
    • +1 more
    Jul 29, 2022

    Chronic Pain Trial in Minneapolis (Medication management, Non-pharmacological pain management, Buprenorphine-Naloxone)

    Completed
    • Chronic Pain
    • Medication management
    • +2 more
    • Minneapolis, Minnesota
      Minneapolis VA Health Care System
    Jan 12, 2023

    Health Insurance Instability Among Patients Receiving Bup Tx for

    Active, not recruiting
    • Health Insurance Instability
    • +2 more
    • No intervention, observational retrospective study
    • Aurora, Colorado
      Kaiser Permanente Colorado
    Jul 5, 2023

    Recovery Trial in Seoul (REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO],

    Not yet recruiting
    • Recovery
    • REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
    • +2 more
    • Seoul, Korea, Republic of
      Department of Anesthesiology and Pain Medicine, Seoul National U
    Jul 29, 2022

    Opioid Use, Unspecified Trial in Chicago (Opioid naive, At-risk for long term use, Long-term opioid recipient)

    Completed
    Has Results
    • Opioid Use, Unspecified
    • Opioid naive
    • +2 more
    • Chicago, Illinois
      Northwestern University
    Jul 21, 2022

    Proenkephalin A and Kidney Replacement Therapy

    Suspended
    • Acute Kidney Injury
    • None planned
    • Gießen, Hessen, Germany
      University Hospital Gießen and Marburg
    Jan 23, 2023

    Withdrawal Symptoms, Opioid Use Disorder, Opioid Use Trial in Atlanta (Transcutaneous Cervical Vagal Nerve Stimulation, Sham

    Not yet recruiting
    • Withdrawal Symptoms
    • +2 more
    • Transcutaneous Cervical Vagal Nerve Stimulation
    • +2 more
    • Atlanta, Georgia
    • +6 more
    Apr 14, 2023